Search research articles
Contact Us
Filters
Showing results (21-30 of 68) with videos related to
Page
of 7
Sort By:
Theranostics
|
June 3, 2014
The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE)
Wenhui Ma, Jia Jia, Shengjun Wang, et al.
Cardiovascular and Interventional Radiology
|
October 24, 2014
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center
Mingwu Li, Ming Bai, Xingshun Qi, et al.
Journal of Hepatology
|
October 12, 2010
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis
Guohong Han, Xingshun Qi, Chuangye He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2014
EASL- and mRECIST-evaluated responses to combination therapy of sorafenib with transarterial chemoembolization predict survival in patients with hepatocellular carcinoma
Lei Liu, Weijuan Wang, Hui Chen, et al.
Radiology
|
November 13, 2012
Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center
Guohong Han, Xingshun Qi, Wei Zhang, et al.
BMC Cancer
|
May 2, 2019
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma
Enxin Wang, Dongdong Xia, Wei Bai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
August 1, 2012
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis
Xingshun Qi, Guohong Han, Chuangye He, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
September 19, 2015
Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children
Yong Lv, Chuangye He, Wengang Guo, et al.
Journal of Gastroenterology and Hepatology
|
December 7, 2011
Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study
Xingshun Qi, Cheng Zhang, Guohong Han, et al.
Journal of Gastroenterology and Hepatology
|
November 12, 2019
Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study
Jiahao Fan, Qiuhe Wang, Bohan Luo, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 68) with videos related to
Sort By:
Page
of 7
Theranostics
|
June 3, 2014
The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE)
Wenhui Ma, Jia Jia, Shengjun Wang, et al.
Cardiovascular and Interventional Radiology
|
October 24, 2014
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center
Mingwu Li, Ming Bai, Xingshun Qi, et al.
Journal of Hepatology
|
October 12, 2010
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis
Guohong Han, Xingshun Qi, Chuangye He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2014
EASL- and mRECIST-evaluated responses to combination therapy of sorafenib with transarterial chemoembolization predict survival in patients with hepatocellular carcinoma
Lei Liu, Weijuan Wang, Hui Chen, et al.
Radiology
|
November 13, 2012
Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center
Guohong Han, Xingshun Qi, Wei Zhang, et al.
BMC Cancer
|
May 2, 2019
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma
Enxin Wang, Dongdong Xia, Wei Bai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
August 1, 2012
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis
Xingshun Qi, Guohong Han, Chuangye He, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
September 19, 2015
Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children
Yong Lv, Chuangye He, Wengang Guo, et al.
Journal of Gastroenterology and Hepatology
|
December 7, 2011
Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study
Xingshun Qi, Cheng Zhang, Guohong Han, et al.
Journal of Gastroenterology and Hepatology
|
November 12, 2019
Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study
Jiahao Fan, Qiuhe Wang, Bohan Luo, et al.
Page
of 7